Skip to main content
logo
Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
11.38
+0.50 (4.60%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Eikon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Market Capitalization
616---
Market Cap Growth
----
Enterprise Value
337---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.540.910.860.07
Net Debt / Equity Ratio
-0.60-0.28-0.07-0.85
Net Debt / EBITDA Ratio
0.880.270.071.57
Net Debt / FCF Ratio
1.080.330.081.82
Quick Ratio
9.616.113.9013.69
Current Ratio
9.896.344.0413.88
Return on Equity (ROE)
--125.02%-69.35%-
Return on Assets (ROA)
--36.19%-32.00%-
Return on Capital Employed (ROCE)
-46.70%-58.30%-59.90%-53.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-831.80%-14.85%-24.35%-
SEC Filings: 10-K · 10-Q